1. Home
  2. BMRA vs HUGE Comparison

BMRA vs HUGE Comparison

Compare BMRA & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • HUGE
  • Stock Information
  • Founded
  • BMRA 1971
  • HUGE 1998
  • Country
  • BMRA United States
  • HUGE Canada
  • Employees
  • BMRA N/A
  • HUGE N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • HUGE Health Care
  • Exchange
  • BMRA Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • BMRA 9.8M
  • HUGE 7.8M
  • IPO Year
  • BMRA N/A
  • HUGE N/A
  • Fundamental
  • Price
  • BMRA $0.33
  • HUGE $0.14
  • Analyst Decision
  • BMRA
  • HUGE
  • Analyst Count
  • BMRA 0
  • HUGE 0
  • Target Price
  • BMRA N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • BMRA 97.3K
  • HUGE 2.5M
  • Earning Date
  • BMRA 08-23-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • BMRA N/A
  • HUGE N/A
  • EPS Growth
  • BMRA N/A
  • HUGE N/A
  • EPS
  • BMRA N/A
  • HUGE N/A
  • Revenue
  • BMRA $5,405,208.00
  • HUGE N/A
  • Revenue This Year
  • BMRA N/A
  • HUGE N/A
  • Revenue Next Year
  • BMRA N/A
  • HUGE N/A
  • P/E Ratio
  • BMRA N/A
  • HUGE N/A
  • Revenue Growth
  • BMRA N/A
  • HUGE N/A
  • 52 Week Low
  • BMRA $0.28
  • HUGE $0.13
  • 52 Week High
  • BMRA $2.13
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 23.13
  • HUGE 29.78
  • Support Level
  • BMRA $0.28
  • HUGE $0.14
  • Resistance Level
  • BMRA $0.39
  • HUGE $0.16
  • Average True Range (ATR)
  • BMRA 0.04
  • HUGE 0.02
  • MACD
  • BMRA -0.00
  • HUGE 0.01
  • Stochastic Oscillator
  • BMRA 27.68
  • HUGE 24.41

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: